Thimerosal exposure & increasing trends of premature puberty in the vaccine safety datalink

Indian Journal of Medical Research

Volumn 131, Issue 4, 2010, Pages 500-507

  Geier, David A ^a,b   Young, Heather A ^c   Geier, Mark R ^d  

^a Institute of Chronic Illnesses Inc   (United States)

^b Department of Research   (United States)

^c GEORGE WASHINGTON UNIVERSITY   (United States)

^d ASD Centers LLC   (United States)

Author keywords

Endocrine; Mercury; Merthiolate; Precocious; Thimerosal; Vaccines

Indexed keywords

DIPHTHERIA PERTUSSIS TETANUS VACCINE; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; HEPATITIS B VACCINE; POLIOMYELITIS VACCINE; THIOMERSAL; VACCINE;

ARTICLE; CHILD; COHORT ANALYSIS; CONGENITAL MALFORMATION; CONTROLLED STUDY; DIPHTHERIA; DRUG EXPOSURE; FEMALE; HEPATITIS B; HUMAN; INFANT; INFLUENZA; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; PERTUSSIS; POLIOMYELITIS; POPULATION RISK; PRECOCIOUS PUBERTY; PRESCHOOL CHILD; PREVALENCE; TETANUS; VACCINATION;

COHORT STUDIES; FEMALE; HUMANS; INFANT; MALE; POISSON DISTRIBUTION; PUBERTY, PRECOCIOUS; THIMEROSAL; VACCINES;

EID: 77951034940     PISSN: 09715916     EISSN: 09715916     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Siddiqi SU, Van Dyke DC, Donohoue P, McBrien DM. Premature sexual development in individuals with neurodevelopmental disabilities. Dev Med Child Neurol 1999; 41: 392-5.
2. Parent AS, Teilmann G, Juul A, Skakkebaek NE, Toppari J, Bourguignon JP. The timing of normal puberty and the age limits of sexual precocity: variations around the world, secular trends, and changes after migration. Endocr Rev 2003; 24: 668-93.
3. van den Hazel P, Zuurbier M, Babisch W, Bartonova A, Bistrup ML, Bolte G, et al. Today's epidemics in children: possible relations to environmental pollution and suggested preventive measures. Acta Paediatr Suppl 2006; 95: 18-25.
4. Geier MR, Geier DA. The potential importance of steroids in the treatment of autistic spectrum disorders and other disorders involving mercury toxicity. Med Hypotheses 2005; 64: 946-54.
5. Plotkin SA. Vaccines' past, present and future. Nat Med 2005; 11(4 Suppl): S5-11.
6. Geier DA, Sykes LK, Geier MR. A review of Thimerosal (Merthiolate) and its ethylmercury breakdown product: specific historical considerations regarding safety and effectiveness. J Toxicol Environ Health B Crit Rev 2007; 10: 575-96.
7. Tan M, Parkin JE. Route of decomposition of thiomersal (Thimerosal). Int J Pharm 2000; 208: 23-34.
8. American Academy of Pediatrics and U.S. Public Health Service. Thimerosal in vaccines: a joint statement of the Centers for Disease Control and Prevention (CDC). MMWR Morb Mortal Wkly Rep 1999; 48: 563-5.
9. Centers for Disease Control and Prevention. Notice to readers: update on the supply of tetanus and diphtheria toxoids and of diphtheria and tetanus toxoids and acellular pertussis vaccine. MMWR Morb Mortal Wkly Rep 2001; 50: 189-90.
10. Knezevic I, Griffiths E, Reigel F, Dobbelaer R. Thiomersal in vaccines: a regulatory perspective. WHO Consultation, Geneva, 15-16 April 2002. Vaccine 2004; 22: 1836-41.
11. Chen RT, DeStefano F, Davis RL, Jackson LA, Thompson RS, Mullooly JP, et al. The Vaccine Safety Datalink: immunization research in health maintenance organizations in the USA. Bull World Health Organ 2000; 78: 186-94.
12. Chen RT, Glasser JW, Rhodes PH, Davis RL, Barlow WE, Thompson RS, et al. Vaccine Safety Datalink project: a new tool for improving vaccine safety monitoring in the United States. The Vaccine Safety Datalink Team. Pediatrics 1997; 99: 765-73.
13. Wassilak SG, Glasser JW, Chen RT, Hadler SC. Utility of large-linked databases in vaccine safety, particularly in distinguishing independent and synergistic effects. The Vaccine Safety Datalink Investigators. Ann NY Acad Sci 1995; 754: 377-82.
14. Young HA, Geier DA, Geier MR. Thimerosal exposure in infants and neurodevelopmental disorders: an assessment of computerized medical records in the Vaccine Safety Datalink. J Neurol Sci 2008; 271: 110-8.
15. Ball LK, Ball R, Pratt RD. An assessment of thimerosal use in childhood vaccines. Pediatrics 2001; 107: 1147-54.
16. Fine PE, Chen RT. Confounding in studies of adverse reactions to vaccines. Am J Epidemiol 1992; 136: 121-35.
17. Cheek DB, Hetzel BS, Hine DC: Evidence of adrenal cortical function in pink disease. Med J Aust 1951; 2: 6-8.
18. Barregard L, Lindstedt G, Schutz A, Sallsten G. Endocrine function in mercury exposed chloralkali workers. Occup Environ Med 1994; 51: 536-40.
19. Freeman HC, Sangalang GB. A study of the effects of methyl mercury, cadmium, arsenic, selenium, and a PCB, (Aroclor 1254) on adrenal and testicular steroidogeneses in vitro, by the gray seal Halichoerus grypus. Arch Environ Contam Toxicol 1977; 5: 369-83.
20. Veltman JC, Maines MD. Alterations of heme, cytochrome P-450, and steroid metabolism by mercury in rat adrenal. Arch Biochem Biophys 1986; 248: 467-478.
21. Ryan RA, Carrol J. Studies on a 3beta-hydroxysteroid sulphotransferase from rat liver. Biochim Biophys Acta 1976; 429: 391-401.
22. Xu F, Suiko M, Sakakibara Y, Pai TG, Liu MC. Regulatory effects of divalent metal cations on human cytosolic sulfotransferases. J Biochem 2002; 132: 457-62.
23. Geier DA, Geier MR. A clinical and laboratory evaluation of methionine cycle-transulfuration and androgen pathway markers in children with autistic disorders. Horm Res 2006; 66: 182-8.
24. Geier DA, Geier MR. A prospective assessment of androgen levels in patients with autistic spectrum disorders: biochemical underpinnings and suggested therapies. Neuro Endocrinol Lett 2007; 28: 565-73.
25. Hinfray N, Porcher JM, Brion F. Inhibition of rainbow trout (Oncorhynchus mykiss) P450 aromatase activities in brain and ovarian microsomes by various environmental substances. Comp Biochem Physiol C Toxicol Pharmacol 2006; 144: 252-62.
26. Mondal S, Mukhopadhyay B, Bhattacharya S. Inorganic mercury binding to fish oocyte plasma membrane induces steroidogenesis and translatable messenger RNA synthesis. Biometals 1997; 10: 285-90.
27. Laks DR. Assessment of chronic mercury exposure within the U.S. population, National Health Nutrition Examination Survey, 1999-2006. Biometals (in press).
28. Blair AMJN, Clark B, Clarke AJ, Wood P. Tissue concentrations of mercury after chronic dosing of squirrel monkeys with thiomersal. Toxicology 1975; 3: 171-6.
29. Gasset AR, Itoi M, Ishii Y, Ramer RM. Teratogenicities of ophthalmic drugs. II. Teratogenicities and tissue accumulation of thimerosal. Arch Ophthalmol 1975; 93: 52-5.
30. Zareba G, Cernichiari E, Hojo R, Nitt SM, Weiss B, Mumtaz MM, et al. Thimerosal distribution and metabolism in neonatal mice: comparison with methyl mercury. J Appl Toxicol 2007; 27: 511-8.
31. Burbacher TM, Shen DD, Liberato N, Grant KS, Cernichiari E, Clarkson T. Comparison of blood and brain mercury levels in infant monkeys exposed to methylmercury or vaccines containing Thimerosal. Environ Health Perspect 2005; 113: 1015-21.
32. Sugita M. The biological half-time of heavy metals. The existence of a third, "slowest" component. Int Arch Occup Environ Health 1978; 41: 25-40.